IP Library Granted Patent US 7,494,787
Granted Patent B2
US 7,494,787 · App. 11/404,063 · Granted Feb 24, 2009

Method for producing yeast expressed HPV types 6 and 16 capsid proteins

Assignee: Novartis Vaccines and Diagnostics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,494,787
App. No.
11/404,063
Granted
Feb 24, 2009
Kind
B2
Abstract

Mosaic VLPs of viral capsid proteins from different virus types are described, as are methods of making the same. Specifically, a diploid yeast strain that coexpresses the L1 and L2 capsid proteins of both HPV-6 and HPV-16 as mosaic VLPs is described. The mosaic VLPs induced the production of conformational antibodies against both L1 proteins upon administration to mice.

Claims (10)

1. A method for producing VLPs comprising capsid proteins from at least two types of viruses, said method comprising

a) cloning said capsid proteins into expression cassettes comprising the same promoters and termination sequences, wherein said capsid proteins comprise a first late 1 (L 1 ) capsid protein from one type of virus and a second L 1 capsid protein from a second type of virus; and

b) expressing said cassettes in the same host cell.

2. The method of claim 1 wherein the host cell is a yeast cell.

3. The method of claim 2 wherein the yeast is Saccharomyces cerevisiae.

4. The method of claim 1 wherein said viruses are different types of HPV.

5. The method of claim 1 further comprising L2 capsid proteins.

6. The method of claim 5 wherein said L1 protein expression cassettes are cloned into non-integrative vectors, and said L2 protein expression cassettes are cloned into integrative vectors.

7. The method of claim 6 wherein the non-integrative vector is pBS24. 1.

8. The method of claim 6 wherein the integrative vector is pUC8.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2010
From: NOVARTIS VACCINES & DIAGNOSTICS, SRL
To: NOVARTIS VACCINES & DIAGNOSTICS, INC
Reel/Frame 024903/0393 →
CHANGE OF NAME Recorded Aug 6, 2010
From: CHIRON SRL
To: NOVARTIS VACCINES AND DIAGNOSTICS SRL
Reel/Frame 024800/0330 →
CHANGE OF NAME Recorded Aug 6, 2010
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 024800/0395 →
Continuity (3)
Division 0976276200
Provisional Application 6009662500 · Aug 14, 1998
Related Publication 20070105194A1 · May 10, 2007